In the present study, we aimed to identify molecular features of small-molecule compounds capable of inhibiting the expression of the ataxin-2 (ATXN2) gene, which is implicated in Spinocerebellar Ataxia Type 2 (SCA2). Here, ATXN2 is linked to spinocerebellar ataxia type 2.